ARVN.NASDAQArvinas, INC

Form 4: Arvinas Director John Young Reports Stock and Option Awards

Sentiment:

SEC Form 4 Filing


Director John Young reports the acquisition of restricted stock units and stock options in Arvinas, Inc.

Summary

  • On May 29, 2024, Director John Young reported acquiring 5,899 shares of common stock through restricted stock units (RSUs) and options to purchase 9,070 shares of common stock.
  • The RSUs and options vest on the earlier of May 29, 2025, or the first board meeting after the next annual stockholder meeting.
  • Following the transaction, Young directly owns 10,020 shares of Arvinas common stock and options to purchase 9,070 shares.
  • Young has granted a Limited Power of Attorney to John Houston, Randy Teel, Jared Freedberg, and Christina Bailey for Section 16 reporting obligations.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock and option awards to a director, which is a common practice. There's no indication of positive or negative news about the company's performance.

Positives

  • The grant of RSUs and stock options to a director aligns their interests with those of the shareholders.
  • The vesting schedule encourages continued service and contribution to the company.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders, such as directors and officers, in the company's securities. This allows investors to monitor insider activity, which can provide insights into management's perspective on the company's prospects.

Comparison to Industry Standards

  • Stock option and RSU grants are a common form of compensation for directors in publicly traded companies, particularly in the biotechnology sector.
  • Vesting schedules tied to continued service are standard practice to incentivize long-term commitment.
  • The size of the grant is typical for a director at a company of Arvinas's size and stage of development, but without knowing the full compensation package it is difficult to compare.

Stakeholder Impact

  • The grant of equity to a director aligns their interests with those of shareholders, potentially encouraging decisions that benefit the company's long-term value.

Key Dates

DateDescription
05/29/2024Date of transaction: Grant of restricted stock units and stock options.
05/29/2025Vesting date for RSUs and stock options (or the first board meeting after the next annual stockholder meeting, if earlier).
05/28/2034Expiration date for the stock options.
05/30/2024Date of execution for the Limited Power of Attorney.
05/31/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.